4wfe:D     (ILE2) to   (LEU105)  HUMAN TRAAK K+ CHANNEL IN A K+ BOUND CONDUCTIVE CONFORMATION  |   MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN 
4wfe:F     (ILE2) to   (LEU105)  HUMAN TRAAK K+ CHANNEL IN A K+ BOUND CONDUCTIVE CONFORMATION  |   MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN 
4wff:D     (ILE2) to   (LEU105)  HUMAN TRAAK K+ CHANNEL IN A K+ BOUND NONCONDUCTIVE CONFORMATION  |   MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN 
4wff:F     (ILE2) to   (LEU105)  HUMAN TRAAK K+ CHANNEL IN A K+ BOUND NONCONDUCTIVE CONFORMATION  |   MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN 
4wfg:D     (ILE2) to   (LEU105)  HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND CONDUCTIVE CONFORMATION  |   MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN 
4wfg:F     (ILE2) to   (LEU105)  HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND CONDUCTIVE CONFORMATION  |   MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN 
4wfh:D     (ILE2) to   (LEU105)  HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION  |   MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN 
4wfh:F     (ILE2) to   (LEU105)  HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION  |   MECHANOSENSITIVE ION CHANNEL, TWO-PORE DOMAIN POTASSIUM ION CHANNEL, MEMBRANE PROTEIN 
1ncc:L     (MET4) to   (ILE106)  CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE  |   HYDROLASE(O-GLYCOSYL) 
4gw5:A     (ILE2) to   (THR109)  CQYN MEDITOPE - CETUXIMAB FAB  |   IGG, IMMUNE SYSTEM, EGFR 
4gw5:C     (ILE2) to   (THR109)  CQYN MEDITOPE - CETUXIMAB FAB  |   IGG, IMMUNE SYSTEM, EGFR 
1a8j:H     (ALA3) to   (VAL109)  IMMUNOGLOBULIN LAMBDA LIGHT CHAIN DIMER (MCG) COMPLEX WITH ASPARTAME  |   ASPARTAME, LIGAND BINDING, IMMUNOTHERAPEUTIC AGENT, SURROGATE RECEPTOR, MCG(HUMAN) BENCE-JONES DIMER, IMMUNOGLOBULIN 
1aif:L     (ILE2) to   (ILE107)  ANTI-IDIOTYPIC FAB 409.5.3 (IGG2A) FAB FROM MOUSE  |   IMMUNOGLOBULIN, C REGION, V REGION 
1aif:A     (ILE2) to   (ILE107)  ANTI-IDIOTYPIC FAB 409.5.3 (IGG2A) FAB FROM MOUSE  |   IMMUNOGLOBULIN, C REGION, V REGION 
2osl:L     (ILE2) to   (ILE105)  CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE  |   FAB-PEPTIDE COMPLEX, RITUXIMAB, CHIMERIC ANTIBODY, IMMUNE SYSTEM 
2osl:B     (ILE2) to   (ILE105)  CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE  |   FAB-PEPTIDE COMPLEX, RITUXIMAB, CHIMERIC ANTIBODY, IMMUNE SYSTEM 
2otu:A     (LEU2) to   (VAL114)  CRYSTAL STRUCTURE OF FV POLYGLUTAMINE COMPLEX  |   ANTIBODY FV POLYGLUTAMINE COMPLEX, IMMUNE SYSTEM 
2otw:A     (LEU2) to   (VAL114)  CRYSTAL STRUCTURE OF FV POLYGLUTAMINE COMPLEX  |   ANTIBODY, POLYGLUTAMINE, COMPLEX, IMMUNE SYSTEM 
4h88:L     (ILE2) to   (LEU106)  STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC FRAGMENT 120- 230  |   C-TERM MOUSE PRION PROTEIN, POM1 FAB, IMMUNE SYSTEM 
4hc1:L     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB 10G3  |   IMMUNOGLOBULIN SUPERFAMILY, ROLLING AND FIRM ADHESION, INTEGRIN ALPHA4BETA7, IMMUNE SYSTEM 
4hc1:N     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB 10G3  |   IMMUNOGLOBULIN SUPERFAMILY, ROLLING AND FIRM ADHESION, INTEGRIN ALPHA4BETA7, IMMUNE SYSTEM 
2p7t:B     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF KCSA MUTANT  |   KCSA, MEMBRANE PROTEIN 
3s35:L     (ASP1) to   (LEU110)  STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES  |   ANTIBODY, KDR, VEGF RECEPTOR, CANCER, IMMUNE SYSTEM-TRANSFERASE COMPLEX 
1bfo:A     (LYS3) to   (LEU106)  CAMPATH-1G IGG2B RAT MONOCLONAL FAB  |   ANTIBODY, FAB, CAMPATH-1G, CD52 
1bfo:C     (LYS3) to   (LEU106)  CAMPATH-1G IGG2B RAT MONOCLONAL FAB  |   ANTIBODY, FAB, CAMPATH-1G, CD52 
1bfo:E     (LYS3) to   (LEU106)  CAMPATH-1G IGG2B RAT MONOCLONAL FAB  |   ANTIBODY, FAB, CAMPATH-1G, CD52 
1bfo:G     (LYS3) to   (LEU106)  CAMPATH-1G IGG2B RAT MONOCLONAL FAB  |   ANTIBODY, FAB, CAMPATH-1G, CD52 
3eyf:C     (ILE2) to   (ILE107)  CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9 PLUS GB PEPTIDE  |   CYTOMEGALOVIRUS, ANTIBODY, IMMUNOGLOBULIN DOMAIN, CLEAVAGE ON PAIR OF BASIC RESIDUES, ENVELOPE PROTEIN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRION, IMMUNE SYSTEM 
3eyq:C     (VAL3) to   (ILE107)  CRYSTAL STRUCTURE OF MJ5 FAB, A GERMLINE ANTIBODY VARIANT OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9  |   HUMAN CYTOMEGALOVIRUS, ANTIBODY, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
2bob:B     (ILE2) to   (ILE106)  POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRABUTYLAMMONIUM (TBA)  |   IMMUNE SYSTEM/TRANSPORT PROTEIN, COMPLEX (ANTIBODY/ION CHANNEL), POTASSIUM CHANNEL, ION TRANSPORT, IONIC CHANNEL, PROTEIN- ANTIBODY FAB COMPLEX 
3f5w:B     (ILE2) to   (ALA109)  KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 32 A OPENING AT T112  |   POTASSIUM CHANNEL, KCSA, OPEN, INACTIVATED, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL, MEMBRANE PROTEIN-METAL TRANSPORT COMPLEX 
2brr:L     (VAL3) to   (ALA109)  COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34)  |   IMMUNE SYSTEM, FAB FRAGMENT, ANTI-PORA ANTIBODY, P1.4 ANTIBODY, ANTIGEN, PORIN, TRANSMEMBRANE, ANTIBODY/ANTIGEN COMPLEX 
2brr:X     (ASN2) to   (ALA109)  COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34)  |   IMMUNE SYSTEM, FAB FRAGMENT, ANTI-PORA ANTIBODY, P1.4 ANTIBODY, ANTIGEN, PORIN, TRANSMEMBRANE, ANTIBODY/ANTIGEN COMPLEX 
3f7y:B     (ILE2) to   (ALA109)  KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 17 A OPENING AT T112  |   KCSA, OPEN, INACTIVATION, POTASSIUM CHANNEL, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL, MEMBRANE PROTEIN-METAL TRANSPORT COMPLEX 
3fb6:B     (ILE2) to   (ALA109)  KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 16 A OPENING AT T112  |   KCSA, OPEN, INACTIVATION, POTASSIUM CHANNEL, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL, MEMBRANE PROTEIN-METAL TRANSPORT COMPLEX 
3fb8:B     (ILE2) to   (ALA109)  KCSA POTASSIUM CHANNEL IN THE OPEN-CONDUCTIVE STATE WITH 20 A OPENING AT T112 IN THE PRESENCE OF RB+ ION  |   KCSA, OPEN, INACTIVATION, POTASSIUM CHANNEL, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL, MEMBRANE PROTEIN-METAL TRANSPORT COMPLEX 
1bww:A     (ILE4) to   (ILE108)  BENCE-JONES IMMUNOGLOBULIN REI VARIABLE PORTION, T39K MUTANT  |   REIV, STABILIZED IMMUNOGLOBULIN FRAGMENT, BENCE-JONES PROTEIN, IMMUNE SYSTEM 
1bww:B     (ILE4) to   (ILE108)  BENCE-JONES IMMUNOGLOBULIN REI VARIABLE PORTION, T39K MUTANT  |   REIV, STABILIZED IMMUNOGLOBULIN FRAGMENT, BENCE-JONES PROTEIN, IMMUNE SYSTEM 
4ht1:L     (ALA1) to   (THR113)  HUMAN TWEAK IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING ANTIBODY  |   ANTIBODY FAB, TNF HOMOLOGY DOMAIN, CYTOKINE, TWEAK RECEPTOR, MEMBRANE BOUND, EXTRACELLULAR THD DOMAIN, IMMUNE SYSTEM 
2bx5:E     (ILE2) to   (ILE106)  IS FR1 THE ANTIBODY'S ACHILLIES HEEL  |   IMMUNE SYSTEM, AMYLOID, LCDD, ANTIBODY, AGGREGATION, FR1 
2bx5:J     (ILE2) to   (ILE106)  IS FR1 THE ANTIBODY'S ACHILLIES HEEL  |   IMMUNE SYSTEM, AMYLOID, LCDD, ANTIBODY, AGGREGATION, FR1 
2bx5:L     (ASP1) to   (ILE106)  IS FR1 THE ANTIBODY'S ACHILLIES HEEL  |   IMMUNE SYSTEM, AMYLOID, LCDD, ANTIBODY, AGGREGATION, FR1 
4xi5:C     (ASP1) to   (ILE106)  GHGL OF VARICELLA-ZOSTER VIRUS IN COMPLEX WITH HUMAN NEUTRALIZING ANTIBODIES  |   COMPLEX, NEUTRALIZATION EPITOPE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3sm5:L     (SER2) to   (VAL107)  INFLUENZA HEMAGGLUTININ IN COMPLEX WITH A NEUTRALIZING ANTIBODY  |   INFLUENZA HEMAGGLUTININ, IMMUNE SYSTEM 
3sm5:M     (SER2) to   (VAL107)  INFLUENZA HEMAGGLUTININ IN COMPLEX WITH A NEUTRALIZING ANTIBODY  |   INFLUENZA HEMAGGLUTININ, IMMUNE SYSTEM 
3sm5:N     (SER2) to   (VAL107)  INFLUENZA HEMAGGLUTININ IN COMPLEX WITH A NEUTRALIZING ANTIBODY  |   INFLUENZA HEMAGGLUTININ, IMMUNE SYSTEM 
1orq:A     (ASN2) to   (ALA110)  X-RAY STRUCTURE OF A VOLTAGE-DEPENDENT POTASSIUM CHANNEL IN COMPLEX WITH AN FAB  |   POTASSIUM CHANNEL, VOLTAGE-DEPENDENT, KVAP, FAB COMPLEX, MEMBRANE PROTEIN 
4i9w:D     (ILE2) to   (LEU105)  HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE  |   POTASSIUM ION CHANNEL, METAL TRANSPORT 
4i9w:F     (ILE2) to   (LEU105)  HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE  |   POTASSIUM ION CHANNEL, METAL TRANSPORT 
1otu:F     (ASP1) to   (ALA108)  STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148Q MUTANT AND FAB COMPLEX  |   ION CHANNEL, CLC CHLORIDE CHANNEL, FAB COMPLEX, MEMBRANE PROTEIN 
2q20:A     (ILE2) to   (ILE106)  STRUCTURE OF THE GERMLINE VK1 O18/O8 LIGHT CHAIN VARIABLE DOMAIN HOMODIMER  |   VK1, GERMLINE, AL, LIGHT CHAIN AMYLOIDOSIS, AMYLOID, IMMUNOGLOBULIN, LIGHT CHAIN, LIGHT CHAIN VARIABLE DOMAIN, PROTEIN FIBRIL 
3sqo:L     (ILE2) to   (ILE106)  PCSK9 J16 FAB COMPLEX  |   CHOLESTEROL REGULATION, LDLR, HYDROLASE-IMMUNE SYSTEM COMPLEX 
1ct8:A     (VAL3) to   (ALA109)  CATALYTIC ANTIBODY 7C8 COMPLEX  |   ABZYME TRANSITION STATE ANALOG, IMMUNE SYSTEM 
3stz:B     (ASP1) to   (ALA109)  KCSA POTASSIUM CHANNEL MUTANT Y82C WITH NITROXIDE SPIN LABEL  |   TRANSMEMBRANE PROTEIN, ION CHANNEL, KCSA POTASSIUM CHANNEL, INACTIVATION, SPIN-LABEL, MEMBRANE PROTEIN 
2q76:A     (ILE2) to   (ILE106)  MOUSE ANTI-HEN EGG WHITE LYSOZYME ANTIBODY F10.6.6 FAB FRAGMENT  |   ANTIBODY, FAB FRAGMENT, LYSOZYME, AFFINITY MATURATION, VH- VL INTERFACE., IMMUNE SYSTEM 
4xnu:L     (VAL3) to   (MET107)  X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER IN COMPLEX WITH NISOXETINE  |   INTEGRAL MEMBRANE PROTEIN, ALL-ALPHA HELICAL ANTIDEPRESSANT COMPLEX, TRANSPORT PROTEIN-INHIBITOR COMPLEX 
4xnx:L     (GLU1) to   (MET107)  X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER IN COMPLEX WITH REBOXETINE  |   INTEGRAL MEMBRANE PROTEIN, ALL-ALPHA HELICAL ANTIDEPRESSANT COMPLEX, TRANSPORT PROTEIN-INHIBITOR COMPLEX 
4xp1:L     (VAL3) to   (MET107)  X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO NEUROTRANSMITTER DOPAMINE  |   INTEGRAL MEMBRANE PROTEIN, MEMBRANE PROTEIN-TRANSPORT PROTEIN COMPLEX 
4xp4:L     (VAL3) to   (MET107)  X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER IN COMPLEX WITH COCAINE  |   INTEGRAL MEMBRANE PROTEIN, ALL-ALPHA HELICAL ANTIDEPRESSANT COMPLEX, MEMBRANE PROTEIN-TRANPORT PROTEIN COMPLEX, TRANSPORT PROTEIN- INHIBITOR COMPLEX 
4xp9:L     (VAL3) to   (MET107)  X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO PSYCHOSTIMULANT D-AMPHETAMINE  |   INTEGRAL MEMBRANE PROTEIN, ALL-ALPHA HELICAL ANTIDEPRESSANT COMPLEX, MEMBRANE PROTEIN, PROTEIN TRANSPORT, TRANSPORT PROTEIN-INHIBITOR COMPLEX 
4xpf:L     (VAL3) to   (MET107)  X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS (D121G/S426M) BOUND TO RTI-55  |   ALL ALPHA-HELICAL INTEGRAL MEMBRANE PROTEIN, TRANSPORT PROTEIN- INHIBITOR COMPLEX 
4xph:L     (ASN2) to   (ALA110)  X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS (D121G/S426M) BOUND TO 3,4DICHLOROPHENETHYLAMINE  |   INTEGRAL MEMBRANE PROTEIN, NEUROTRANSMITTER TRANSPORTER, PROTEIN TRANSPORT-INHIBITOR COMPLEX 
3t2n:L     (THR2) to   (VAL106)  HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY  |   TYPE II TRANSMEMBRANE SERINE PROTEASE, SRCR DOMAIN, SUBSTRATES INCLUDE PRO-HEPSIN, PRO-HGF, LAMININ-332, TRANSMEMBRANE, HYDROLASE 
3gb7:B     (ILE2) to   (ALA109)  POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+  |   ION-CHANNEL, ION SELECTIVITY, POTASSIUM TRANSPORT, LITHIUM BLOCK, MEMBRANE PROTEIN, INTEGRAL MEMBRANE PROTEIN, VOLTAGE-GATED POTASSIUM CHANNEL, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL 
2qql:L     (ILE2) to   (THR109)  NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB  |   VEGF RECEPTOR, SEMAPHORIN RECEPTOR, PHAGE-DERIVED ANTIBODY, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, GLYCOPROTEIN, MEMBRANE, NEUROGENESIS, TRANSMEMBRANE, HORMONE, SIGNALING PROTEIN 
1e6o:L     (GLU1) to   (ILE104)  CRYSTAL STRUCTURE OF FAB13B5 AGAINST HIV-1 CAPSID PROTEIN P24  |   IMMUNOGLOBULIN, FAB, ANTIBODY, ANTIGEN, HIV-1, P24, CA 
4j8r:C     (ASP1) to   (ILE104)  STRUCTURE OF AN OCTAPEPTIDE REPEAT OF THE PRION PROTEIN BOUND TO THE POM2 FAB ANTIBODY FRAGMENT  |   IMMUNOGLOBULIN FOLD, FAB, ANTIBODY, OCTAPEPTIDE REPEAT, MOUSE PRION PROTEIN, IMMUNE SYSTEM 
1eap:A     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF A CATALYTIC ANTIBODY WITH A SERINE PROTEASE ACTIVE SITE  |   CATALYTIC ANTIBODY 
2r9h:F     (ASP1) to   (ILE105)  CRYSTAL STRUCTURE OF Q207C MUTANT OF CLC-EC1 IN COMPLEX WITH FAB  |   CLC, ANTIPORTER, TRANSPORTER, EXCHANGER, DISULFIDE, CROSSLINK, MEMBRANE PROTEIN, CHLORIDE, INNER MEMBRANE, ION TRANSPORT, STRESS RESPONSE, TRANSMEMBRANE 
3tnm:L     (VAL4) to   (VAL106)  CRYSTAL STRUCTURE OF A32 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY  |   ADCC, NON-NEUTRALIZING, ANTI-HIV-1 ENV ANTIBODY A32, CD4I ANTIBODY, FAB, VIRAL GLYCOPROTEIN GP120, HIV-1 ENV, IMMUNE SYSTEM 
1ejo:L  (ASP2001) to  (LEU2110)  FAB FRAGMENT OF NEUTRALISING MONOCLONAL ANTIBODY 4C4 COMPLEXED WITH G-H LOOP FROM FMDV.  |   FMDV, ANTIGENIC-ANTIBODY INTERACTIONS, RGD MOTIF, G-H LOOP OF VP1., IMMUNE SYSTEM 
4ydj:L     (SER2) to   (VAL106)  CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 44- VRC13.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120  |   ANTIBODY, HIV-1, IMMUNE SYSTEM 
4ydj:B     (SER2) to   (VAL106)  CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 44- VRC13.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120  |   ANTIBODY, HIV-1, IMMUNE SYSTEM 
3tt3:L     (ASP1) to   (ALA113)  CRYSTAL STRUCTURE OF LEUT IN THE INWARD-OPEN CONFORMATION IN COMPLEX WITH FAB  |   LEUT FOLD, TRANSPORTER, PLASMA MEMBRANE, TRANSPORT PROTEIN 
3tv3:L     (ALA3) to   (THR105)  CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT128 IN COMPLEX WITH MAN9  |   FAB, HIV-1 NEUTRALIZING ANTIBODY, GP120, IMMUNE SYSTEM 
4jlr:L     (ASP1) to   (THR109)  CRYSTAL STRUCTURE OF A DESIGNED RESPIRATORY SYNCYTIAL VIRUS IMMUNOGEN IN COMPLEX WITH MOTAVIZUMAB  |   ANTIBODY, DESIGNED IMMUNOGEN, SPECIFIC BINDING, RSV F PROTEIN, IMMUNE SYSTEM 
3u30:E     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF A LINEAR-SPECIFIC UBIQUITIN FAB BOUND TO LINEAR UBIQUITIN  |   IMMUNE SYSTEM 
1f58:L     (VAL3) to   (LEU106)  IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 24-RESIDUE PEPTIDE (RESIDUES 308-333 OF HIV-1 GP120 (MN ISOLATE) WITH ALA TO AIB SUBSTITUTION AT POSITION 323  |   IMMUNOGLOBULIN, FAB, HIV-1, GP120, V3, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX 
1r3j:A     (ILE2) to   (ALA109)  POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF TL+  |   MEMBRANE PROTEIN, POTASSIUM CHANNEL, KCSA-FAB COMPLEX, THALLIUM 
1r3k:A     (ILE2) to   (ALA109)  POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF TL+  |   MEMBRANE PROTEIN, POTASSIUM CHANNEL, KCSA-FAB COMPLEX, THALLIUM 
4k3h:A     (GLN1) to   (LEU106)  IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATIONG PROTEIN IN COMPLEX WITH MALACHITE GREEN  |   IMMUNOGLOBULIN FOLD, FLUORESCENSCE, MALACHITE GREEN, O-MANNOSYLATION, THR27, IMMUNE SYSTEM-INHIBITOR COMPLEX 
4k3h:F     (GLN1) to   (LEU106)  IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATIONG PROTEIN IN COMPLEX WITH MALACHITE GREEN  |   IMMUNOGLOBULIN FOLD, FLUORESCENSCE, MALACHITE GREEN, O-MANNOSYLATION, THR27, IMMUNE SYSTEM-INHIBITOR COMPLEX 
2ez0:F     (ASP1) to   (ILE105)  CRYSTAL STRUCTURE OF THE S107A/E148Q/Y445A MUTANT OF ECCLC, IN COMPLEX WITH A FAB FRAGMENT  |   CLC FAMILY OF CHANNELS AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN/FAB COMPLEX 
1rei:B     (GLN3) to   (ILE106)  THE MOLECULAR STRUCTURE OF A DIMER COMPOSED OF THE VARIABLE PORTIONS OF THE BENCE-JONES PROTEIN REI REFINED AT 2.0 ANGSTROMS RESOLUTION  |   IMMUNOGLOBULIN(PART)SEQUESTERS ANTIGENS 
1fsk:B     (ILE2) to   (ALA109)  COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1  |   BET V 1, BV16 FAB FRAGMENT, ANTIBODY ALLERGEN COMPLEX, IMMUNE SYSTEM 
1fsk:E     (ILE2) to   (ALA109)  COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1  |   BET V 1, BV16 FAB FRAGMENT, ANTIBODY ALLERGEN COMPLEX, IMMUNE SYSTEM 
1fsk:H     (ILE2) to   (ALA109)  COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1  |   BET V 1, BV16 FAB FRAGMENT, ANTIBODY ALLERGEN COMPLEX, IMMUNE SYSTEM 
1fsk:K     (ILE2) to   (ALA109)  COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1  |   BET V 1, BV16 FAB FRAGMENT, ANTIBODY ALLERGEN COMPLEX, IMMUNE SYSTEM 
4ywg:M     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF 830A IN COMPLEX WITH V1V2  |   HIV-1 GP120, THE V1V2 REGION, ANTIBODY, COMPLEX STRUCTURE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4yx2:L     (ASP1) to   (LEU106)  CRYSTAL STRUCTURE OF BOVINE PRION PROTEIN COMPLEXED WITH POM1 FAB  |   PRION, ANTIBODY, COMPLEX, IMMUNE SYSTEM COMPLEX, IMMUNE SYSTEM 
3uls:L     (SER2) to   (VAL106)  CRYSTAL STRUCTURE OF FAB12  |   TOLL-LIKE RECEPTOR-3, TLR3, INNATE IMMUNITY, IMMUNOGLOBULIN, IMMUNE SYSTEM 
4kaq:L     (VAL3) to   (THR108)  STRUCTURE OF RITUXIMAB FAB  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
4yxk:L     (ASP1) to   (LEU106)  CRYSTAL STRUCTURE OF ELK PRION PROTEIN COMPLEXED WITH POM1 FAB  |   PRION, ANTIBODY, IMMUNE SYSTEM COMPLEX, IMMUNE SYSTEM 
4yxl:L     (ILE2) to   (LEU106)  CRYSTAL STRUCTURE OF SYRIAN HAMSTER PRION PROTEIN COMPLEXED WITH POM1 FAB  |   PRION, ANTIBODY, IMMUNE SYSTEM COMPLEX, IMMUNE SYSTEM 
2fat:L     (ASP1) to   (ILE106)  AN ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) ANTIBODY: CRYSTAL STRUCTURE AND BINDING EPITOPE  |   ANTI-UPAR ANTIBODY, ATN-615, FAB, CRYSTAL STRUCTURE, IMMUNE SYSTEM 
2vdl:L     (ILE2) to   (ILE106)  RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE  |   CELL ADHESION-IMMUNE SYSTEM COMPLEX, FIBRINOGEN BINDING, PLATELET INTEGRIN ALPHAIIBBETA3, GLYCOPROTEIN, CELL ADHESION, MEMBRANE, INTEGRIN, RECEPTOR, ANTAGONIST, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, TRANSMEMBRANE, PHOSPHORYLATION, DISEASE MUTATION, CLEAVAGE ON PAIR OF BASIC RESIDUES, CELL ADHESION/IMMUNE SYSTEM COMPLEX 
2vdq:L     (ILE2) to   (ILE106)  INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE, HHLGGAKQRGDV  |   CELL ADHESION-IMMUNE SYSTEM COMPLEX, FIBRINOGEN BINDING, PLATELET INTEGRIN ALPHAIIBBETA3, GLYCOPROTEIN, CELL ADHESION, MEMBRANE, INTEGRIN, RECEPTOR, ANTAGONIST, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, TRANSMEMBRANE, PHOSPHORYLATION, DISEASE MUTATION, CLEAVAGE ON PAIR OF BASIC RESIDUES, CELL ADHESION/IMMUNE SYSTEM COMPLEX 
2fl5:L     (SER1) to   (VAL106)  COFACTOR-CONTAINING ANTIBODIES: CRYSTAL STRUCTURE OF THE ORIGINAL YELLOW ANTIBODY  |   HUMAN ANTIBODY, RIBOFLAVIN-BINDING, COFACTOR, MULTIPLE MYELOMA, IGGGAR, IMMUNE SYSTEM 
2fl5:A     (SER1) to   (VAL106)  COFACTOR-CONTAINING ANTIBODIES: CRYSTAL STRUCTURE OF THE ORIGINAL YELLOW ANTIBODY  |   HUMAN ANTIBODY, RIBOFLAVIN-BINDING, COFACTOR, MULTIPLE MYELOMA, IGGGAR, IMMUNE SYSTEM 
1s5h:A     (ILE2) to   (ILE106)  POTASSIUM CHANNEL KCSA-FAB COMPLEX T75C MUTANT IN K+  |   K+ CHANNEL, PROTEIN-ANTIBODY FAB COMPLEX, SELECTIVITY FILTER, ION OCCUPANCY, MEMBRANE PROTEIN 
4kph:L     (ILE2) to   (ALA109)  STRUCTURE OF THE FAB FRAGMENT OF N62, A PROTECTIVE MONOCLONAL ANTIBODY TO THE NONREDUCING END OF FRANCISELLA TULARENSIS O-ANTIGEN  |   ANTIBODY, IMMUNOGLOBULIN, IMMUNE SYSTEM, CARBOHYDRATE/SUGAR BINDING, PLASMA 
4kq4:L     (ASP1) to   (THR109)  CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO7357  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
2w0f:B     (ASP1) to   (ILE106)  POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRAOCTYLAMMONIUM  |   IMMUNE SYSTEM METAL TRANSPORT COMPLEX, QUATERNARY AMMONIUM, PROTEIN-ANTIBODY FAB COMPLEX, IONIC CHANNEL, ION TRANSPORT, POTASSIUM CHANNEL 
3if1:A     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF 237MAB IN COMPLEX WITH A GALNAC  |   GLYCOPEPITDE, ANTIBODY, FAB, CARBOHYDRATE-BIDING, TUMOUR, IMMUNE SYSTEM 
3iga:B     (ILE2) to   (ALA109)  POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+ AND K+  |   KCSA, LITHIUM, LITHIUM BLOCK, POTASSIUM CHANNEL, MEMBRANE PROTEIN, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL, TRANSPORT PROTEIN 
2gsg:C     (LEU2) to   (VAL116)  CRYSTAL STRUCTURE OF THE FV FRAGMENT OF A MONOCLONAL ANTIBODY SPECIFIC FOR POLY-GLUTAMINE  |   FV, MONOCLONAL ANTIBODY, POLY-GLUTAMINE, IMMUNE SYSTEM 
4lbe:B     (ASP1) to   (ALA109)  STRUCTURE OF KCSA WITH R122A MUTATION  |   METAL TRANSPORT, PH-GATED POTASSIUM CHANNEL, TRANSPORT PROTEIN, MEMBRANE PROTEIN 
4zs6:L     (ILE2) to   (ILE105)  RECEPTOR BINDING DOMAIN AND FAB COMPLEX  |   COMPLEX, FAB, RECEPTOR BINDING DOMAIN, IMMUNE SYSTEM 
4zs6:D     (ILE2) to   (ILE105)  RECEPTOR BINDING DOMAIN AND FAB COMPLEX  |   COMPLEX, FAB, RECEPTOR BINDING DOMAIN, IMMUNE SYSTEM 
4lcu:B     (ASP1) to   (ALA109)  STRUCTURE OF KCSA WITH E118A MUTATION  |   VOLTAGE GATED POTASSIUM CHANNEL, POTASSIUM CHANNEL, TRANSPORT PROTEIN, MEMBRANE PROTEIN, PH-GATED POTASSIUM CHANNEL 
2w9d:L     (VAL3) to   (ALA108)  STRUCTURE OF FAB FRAGMENT OF THE ICSM 18 - ANTI-PRP THERAPEUTIC ANTIBODY   AT 1.57 A RESOLUTION.  |   IMMUNE SYSTEM, PRION, PRP, FAB 
1hil:A     (VAL3) to   (LEU106)  STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIGEN-ANTIBODY RECOGNITION  |   IMMUNOGLOBULIN 
2h8p:B     (ILE2) to   (ALA109)  STRUCTURE OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER  |   CHANNEL, SEMI-SYNTHETIC, ESTER, MEMBRANE PROTEIN 
2hfe:B     (ASP1) to   (ALA109)  RB+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER  |   CHANNEL, SEMI-SYNTHETIC, ESTER, MEMBRANE PROTEIN 
2hg5:B     (ILE2) to   (ALA109)  CS+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER  |   CHANNEL, SEMI-SYNTHETIC, ESTER, MEMBRANE PROTEIN 
3iy5:A     (ILE2) to   (ILE107)  VARIABLE DOMAINS OF THE MOUSE FAB (1AIF) FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS-FAB 16 COMPLEX  |   CRYOEM, NEUTRALIZING ANTIBODY, PARVOVIRUS, CANINE, FELINE, FAB FOOTPRINT, IMMUNE SYSTEM 
4llv:B     (ILE2) to   (VAL106)  THE STRUCTURE OF THE UNBOUND FORM OF ANTI-HIV ANTIBODY 4E10 FV  |   4E10, FV, HIV, IMMUNOGLOBULIN, ANTIBODY, IMMUNE SYSTEM 
4llv:L     (VAL3) to   (LYS107)  THE STRUCTURE OF THE UNBOUND FORM OF ANTI-HIV ANTIBODY 4E10 FV  |   4E10, FV, HIV, IMMUNOGLOBULIN, ANTIBODY, IMMUNE SYSTEM 
2hjf:B     (ILE2) to   (ALA109)  POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRABUTYLAMMONIUM (TBA)  |   POTASSIUM CHANNEL, ION TRANSPORT, METAL TRANSPORT 
3w11:D     (ASP1) to   (ILE111)  INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HUMAN INSULIN, ALPHA-CT PEPTIDE(704-719) AND FAB 83-7  |   CELL SURFACE RECEPTOR/IMMUNE SYSTEM, INSULIN RECEPTOR, IR ECTODOMAIN, CT PEPTIDE, INSULIN, HORMONE-HORMONE RECEPTOR-IMMUNE SYSTEM COMPLEX 
2htl:D     (ASP1) to   (ILE105)  STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445F MUTANT AND FAB COMPLEX  |   CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX 
2hvk:B     (ILE2) to   (ALA109)  CRYSTAL STRUCTURE OF THE KCSA-FAB-TBA COMPLEX IN HIGH K+  |   POTASSIUM CHANNEL, MEMBRANE PROTEIN, TETRABUTYLAMMONIUM, K+, KCSA 
4m43:L     (LEU2) to   (LEU106)  CRYSTAL STRUCTURE OF ANTI-RABIES GLYCOPROTEIN FAB 523-11  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
4m48:L     (VAL3) to   (MET107)  X-RAY STRUCTURE OF DOPAMINE TRANSPORTER ELUCIDATES ANTIDEPRESSANT MECHANISM  |   SLC6, NEUROTRANSMITTER TRANSPORTER, TRANSPORT PROTEIN 
2icc:A     (PRO2) to   (LYS118)  EXTRACELLULAR DOMAIN OF CRIG  |   ALTERNATIVE PATHWAY, COMPLEMENT RECEPTOR, IG LIKE DOMAIN, IMMUNE SYSTEM 
2iff:L     (VAL3) to   (ILE104)  STRUCTURE OF AN ANTIBODY-LYSOZYME COMPLEX: EFFECT OF A CONSERVATIVE MUTATION  |   IMMUNOGLOBULIN/HYDROLASE(O-GLYCOSYL), IMMUNOGLOBULIN-HYDROLASE(O- GLYCOSYL) COMPLEX 
4ma8:L     (ILE2) to   (LEU106)  CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH CHLORPROMAZINE  |   IMMUNOGLOBULIN FOLD, FAB, ANTIBODY, MOUSE PRION PROTEIN, IMMUNE SYSTEM 
1ivl:B     (ILE2) to   (ILE106)  THE DE NOVO DESIGN OF AN ANTIBODY COMBINING SITE: CRYSTALLOGRAPHIC ANALYSIS OF THE VL DOMAIN CONFIRMS THE STRUCTURAL MODEL  |   IMMUNOGLOBULIN 
2ih1:B     (ILE2) to   (ALA109)  ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION  |   ION CHANNEL D-AMINO ACID SEMI-SYNTHETIC, MEMBRANE PROTEIN 
2ih3:B     (ILE2) to   (ILE106)  ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION  |   ION CHANNEL D-AMINO ACID SEMI-SYNTHETIC, MEMBRANE PROTEIN 
1uwg:L     (LEU2) to   (ILE106)  MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9  |   ANTIBODY, CATALYTIC ANTIBODY 
1uwg:X     (LEU2) to   (ILE106)  MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9  |   ANTIBODY, CATALYTIC ANTIBODY 
1j05:L     (VAL3) to   (ILE106)  THE CRYSTAL STRUCTURE OF ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY T84.66 FV FRAGMENT  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
4mhh:L     (VAL3) to   (ALA109)  CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)  |   H5N1 INFLUENZA VIRUS, BROADLY NEUTRALIZING MURINE ANTIBODY, ESCAPE MUTANT, PASSIVE IMMUNOTHERAPY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4mhh:I     (VAL3) to   (ILE106)  CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)  |   H5N1 INFLUENZA VIRUS, BROADLY NEUTRALIZING MURINE ANTIBODY, ESCAPE MUTANT, PASSIVE IMMUNOTHERAPY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4mhh:K     (VAL3) to   (ILE106)  CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)  |   H5N1 INFLUENZA VIRUS, BROADLY NEUTRALIZING MURINE ANTIBODY, ESCAPE MUTANT, PASSIVE IMMUNOTHERAPY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
5anm:A     (LEU4) to   (VAL110)  CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY  |   IMMUNE SYSTEM, THERAPEUTIC ANTIBODY, IGG, IGE, ASTHMA 
4msw:B     (ILE2) to   (ILE106)  Y78 ESTER MUTANT OF KCSA IN HIGH K+  |   MEMBRANE PROTEIN, CHANNEL, ESTER, UNNATURAL AMINO ACID, TRANSPORT PROTEIN 
3x2d:K     (ILE2) to   (ILE126)  CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78  |   MARBURG, GLYCOPROTEIN, ANTIBODY, VIRUS, NEUTRALIZATION, FUSION, NIEMANN PICK C1 (NPC1) RECEPTOR, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1w72:L     (TYR2) to   (VAL106)  CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB- HYB3  |   IMMUNE SYSTEM, HLA/FAB FRAGMENT, HUMAN LEUCOCYTE ANTIGEN, PEPTIDE-SPECIFIC FAB, TCR-LIKE BINDING, MHC-I 
1w72:M     (TYR2) to   (VAL106)  CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB- HYB3  |   IMMUNE SYSTEM, HLA/FAB FRAGMENT, HUMAN LEUCOCYTE ANTIGEN, PEPTIDE-SPECIFIC FAB, TCR-LIKE BINDING, MHC-I 
2jk5:B     (ILE2) to   (ALA109)  POTASSIUM CHANNEL KCSA IN COMPLEX WITH TETRABUTYLAMMONIUM IN HIGH K  |   IMMUNE SYSTEM-METAL TRANSPORT COMPLEX, QUATERNARY AMMONIUM, PROTEIN-ANTIBODY FAB COMPLEX, IONIC CHANNEL, ION TRANSPORT 
1k4c:B     (ILE2) to   (ALA109)  POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF K+  |   K CHANNEL, PROTEIN-ANTIBODY FAB COMPLEX, MEMBRANE PROTEIN 
1k4d:B     (ILE2) to   (ALA109)  POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF K+  |   K CHANNEL, PROTEIN-ANTIBODY FAB COMPLEX, MEMBRANE PROTEIN 
5bvp:L     (GLU1) to   (ILE106)  THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB, A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA  |   IMMUNOGLOBULIN, FAB, CYTOKINE, BETA TREFOIL, IMMUNE SYSTEM 
4nja:L     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF FAB 6C8 IN COMPLEX WITH MPTS  |   IMMUNOGLOBULIN FOLD, MPTS BINDING, IMMUNE SYSTEM 
2ybr:B   (ILE134) to   (ILE238)  CRYSTAL STRUCTURE OF THE HUMAN DERIVED SINGLE CHAIN ANTIBODY FRAGMENT (SCFV) 9004G IN COMPLEX WITH CN2 TOXIN FROM THE SCORPION CENTRUROIDES NOXIUS HOFFMANN  |   IMMUNE SYSTEM-TOXIN COMPLEX, SCORPION TOXIN 
2ybr:E   (ILE134) to   (ILE238)  CRYSTAL STRUCTURE OF THE HUMAN DERIVED SINGLE CHAIN ANTIBODY FRAGMENT (SCFV) 9004G IN COMPLEX WITH CN2 TOXIN FROM THE SCORPION CENTRUROIDES NOXIUS HOFFMANN  |   IMMUNE SYSTEM-TOXIN COMPLEX, SCORPION TOXIN 
2ybr:H   (ILE134) to   (ILE238)  CRYSTAL STRUCTURE OF THE HUMAN DERIVED SINGLE CHAIN ANTIBODY FRAGMENT (SCFV) 9004G IN COMPLEX WITH CN2 TOXIN FROM THE SCORPION CENTRUROIDES NOXIUS HOFFMANN  |   IMMUNE SYSTEM-TOXIN COMPLEX, SCORPION TOXIN 
4nry:B     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66  |   IMMUNOGLOBULIN, NEUTRALIZING ANTIBODY, HIV-1 GP41, MEMBRANE PROXIMAL EXTERNAL REGION, MPER, IMMUNE SYSTEM 
4nyl:L     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT  |   IMMUNOGLOBULIN FOLDING, ANTIBODY FRAGMENT, TNF ALPHA, IMMUNE SYSTEM 
1xcq:E     (ILE2) to   (ALA115)  COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55A,L57H,Y64W) IN SPACE GROUP P21  |   CRYSTAL PACKING, FAB, PROTEIN L, PEPTIDE COMPLEX, IMMUNE SYSTEM 
2z91:D     (LEU2) to   (VAL106)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9  |   IMMUNOGLOBRIN FOLD, IMMUNE SYSTEM 
2o5x:L     (LEU2) to   (THR109)  CRYSTAL STRUCTURE OF 1E9 LEUH47TRP/ARGH100TRP, AN ENGINEERED DIELS- ALDERASE FAB WITH NM STEROID-BINDING AFFINITY  |   IMMUNOGLOBULIN, CHIMERIC FAB, ANTIBODY ENGINEERING, EVOLUTION OF LIGAND RECOGNITION, IMMUNE SYSTEM 
2o5y:L     (GLU1) to   (THR109)  CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB PROGESTERONE COMPLEX  |   IMMUNOGLOBULIN, CHIMERIC FAB, ANTIBODY ENGINEERING, EVOLUTION OF LIGAND RECOGNITION, IMMUNE SYSTEM 
2o5z:L     (LEU2) to   (THR109)  CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB 5-BETA- ANDROSTANE-3,17-DIONE COMPLEX  |   IMMUNOGLOBULIN, CHIMERIC FAB, ANTIBODY ENGINEERING, EVOLUTION OF LIGAND RECOGNITION, IMMUNE SYSTEM 
2znw:A     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF SCFV10 IN COMPLEX WITH HEN EGG LYSOZYME  |   SINGLE CHAIN FV, LYSOZYME, ALLERGEN, ANTIMICROBIAL, BACTERIOLYTIC ENZYME, GLYCOSIDASE, HYDROLASE, IMMUNE SYSTEM-HYDROLASE COMPLEX 
1mcf:B     (ALA3) to   (VAL109)  PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS  |   IMMUNOGLOBULIN 
3kj6:L     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF A METHYLATED BETA2 ADRENERGIC RECEPTOR- FAB COMPLEX  |   TRANSMEMBRANE HELICES, CELL MEMBRANE, DISULFIDE BOND, G- PROTEIN COUPLED RECEPTOR, GLYCOPROTEIN, LIPOPROTEIN, MEMBRANE, PALMITATE, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSDUCER, TRANSMEMBRANE, SIGNALING PROTEIN 
5d1x:A     (ILE2) to   (ILE106)  ISDB NEAT2 BOUND BY D4-30  |   ISDB, NEAT2, GERMLINE ENCODED, IMMUNE SYSTEM 
1yec:L     (ILE2) to   (ILE106)  STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.3)  |   CATALYTIC ANTIBODY, TRANSITION STATE ANALOGUE 
1yjd:L     (ASP1) to   (ALA109)  CRYSTAL STRUCTURE OF HUMAN CD28 IN COMPLEX WITH THE FAB FRAGMENT OF A MITOGENIC ANTIBODY (5.11A1)  |   IGSF, CD28 HOMODIMER, IMMUNE SYSTEM-SIGNALING PROTEIN COMPLEX 
1yqv:L     (MET0) to   (ILE106)  THE CRYSTAL STRUCTURE OF THE ANTIBODY FAB HYHEL5 COMPLEX WITH LYSOZYME AT 1.7A RESOLUTION  |   HYHEL-5 ANTIBODY, LYSOZYME, IMMUNE SYSTEM 
1yy8:A     (ILE2) to   (THR109)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE MONOCLONAL ANTIBODY CETUXIMAB/ERBITUX/IMC-C225  |   FAB FRAGMENT; ANTIBODY DRUG; CANCER, IMMUNE SYSTEM 
1yy8:C     (ILE2) to   (THR109)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE MONOCLONAL ANTIBODY CETUXIMAB/ERBITUX/IMC-C225  |   FAB FRAGMENT; ANTIBODY DRUG; CANCER, IMMUNE SYSTEM 
5dmi:L     (ILE2) to   (THR109)  STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH CHI220 FAB  |   CELL SURFACE RECEPTOR, ANTIBODY-ANTIGEN COMPLEX, ANTITUMOR, IMMUNE SYSTEM-SIGNALING PROTEIN COMPLEX 
4al8:L     (ASP1) to   (ILE106)  STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12  |   IMMUNE SYSTEM, ANTIBODY, NEUTRALISATION 
4ala:L     (ASP1) to   (ALA109)  STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12  |   IMMUNE SYSTEM, ANTIBODY, NEUTRALISATION 
5dq9:B     (ASP1) to   (ILE106)  STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A  |   ANTIBODY, FAB, COMPLEX, CARBOHYDRATE, IMMUNE SYSTEM 
5dq9:D     (VAL3) to   (ILE106)  STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A  |   ANTIBODY, FAB, COMPLEX, CARBOHYDRATE, IMMUNE SYSTEM 
5dq9:L     (ASP1) to   (ILE106)  STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A  |   ANTIBODY, FAB, COMPLEX, CARBOHYDRATE, IMMUNE SYSTEM 
1zan:L     (ASP1) to   (ALA110)  CRYSTAL STRUCTURE OF ANTI-NGF AD11 FAB  |   IMMUNOGLOBULIN, FAB, IMMUNE SYSTEM 
5dur:D     (ALA3) to   (GLY113)  INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH ANTIBODY 100F4  |   INFLUENZA VIRUS, ANTIBODY, COMPLEX, NEUTRALIZE, IMMUNE SYSTEM 
5dwu:L     (ILE2) to   (ILE106)  BETA COMMON RECEPTOR IN COMPLEX WITH A FAB  |   FAB COMPLEX, ANTIGEN RECOGNITION, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM 
1zlu:K     (VAL2) to   (ILE106)  FAB 2G12 + MAN5  |   HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN- SWAPPING, IMMUNE SYSTEM 
4at6:N     (ALA2) to   (LEU109)  FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7  |   IMMUNE SYSTEM, METALLOPORPHYRIN, CATALYTIC ANTIBODY, PEROXIDASE 
5dyo:L     (ASP1) to   (ILE111)  FAB43.1 COMPLEX WITH FLOURESCEIN  |   ANTIBODY FAB FLOURESCEIN, IMMUNE SYSTEM 
3ls4:L     (ASP1) to   (LEU107)  CRYSTAL STRUCTURE OF ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT IN COMPLEX WITH THC  |   IMMUNE SYSTEM, ANTIBODY, IMMUNOGLOBULIN, FAB FRAGMENT, CANNABINOID COMPLEX 
3ls5:L     (ASP1) to   (LEU107)  ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT, FREE FORM  |   IMMUNE SYSTEM, ANTIBODY, IMMUNOGLOBULIN, FAB FRAGMENT, CANNABINOID COMPLEX 
5e1a:B     (ASP1) to   (ILE106)  STRUCTURE OF KCSA WITH L24C/R117C MUTATIONS  |   KCSA, MUTATION, PROTONS, POTASSIUM CHANNELS, METAL TRANSPORT 
1ztx:L     (ASP1) to   (LEU106)  WEST NILE VIRUS ENVELOPE PROTEIN DIII IN COMPLEX WITH NEUTRALIZING E16 ANTIBODY FAB  |   ANTIBODY, FAB, NEUTRALIZING, VIRUS, ENVELOPE, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX 
5ebw:B     (ILE2) to   (ALA109)  KCSA WITH G77ESTER MUTATION  |   ALPHA-HELICAL, CHANNEL, FAB, MEMBRANE PROTEIN 
5ec1:B     (ILE2) to   (ALA109)  KCSA WITH V76ESTER MUTATION  |   ALPHA HELICAL, CHANNEL, FAB, MEMBRANE PROTEIN 
5ec2:B     (ILE2) to   (ALA109)  KCSA WITH V76ESTER+G77DA MUTATIONS  |   ALPHA-HELICAL, CHANNEL, FAB, MEMBRANE PROTEIN 
3ma9:L     (ILE2) to   (VAL107)  CRYSTAL STRUCTURE OF GP41 DERIVED PROTEIN COMPLEXED WITH FAB 8066  |   GP41, IMMUNE SYSTEM 
2aep:L     (ASP1) to   (ALA109)  AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX.  |   INFLUENZA VIRUS NEURAMINIDASE-FAB COMPLEX, IMMUNE SYSTEM 
2aeq:L     (ASP1) to   (LEU106)  AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX.  |   INFLUENZA VIRUS NEURAMINIDASE-FAB COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX 
4qnp:F     (ILE2) to   (ILE105)  CRYSTAL STRUCTURE OF THE 2009 PANDEMIC H1N1 INFLUENZA VIRUS NEURAMINIDASE WITH A NEUTRALIZING ANTIBODY  |   INFLUENZA, NEURAMINIDASE, ANTIBODY, NEUTRALIZING ANTIBODY, HYDROLASE- IMMUNE SYSTEM COMPLEX 
4qnp:L     (ILE2) to   (ILE105)  CRYSTAL STRUCTURE OF THE 2009 PANDEMIC H1N1 INFLUENZA VIRUS NEURAMINIDASE WITH A NEUTRALIZING ANTIBODY  |   INFLUENZA, NEURAMINIDASE, ANTIBODY, NEUTRALIZING ANTIBODY, HYDROLASE- IMMUNE SYSTEM COMPLEX 
3be1:L     (ASP1) to   (ILE106)  DUAL SPECIFIC BH1 FAB IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF HER2/ERBB-2  |   FAB COMPLEX, ATP-BINDING, GLYCOPROTEIN, KINASE, MEMBRANE, NUCLEOTIDE- BINDING, PHOSPHORYLATION, RECEPTOR, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE 
3mls:O     (SER1) to   (VAL109)  CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE  |   HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, MIMOTOPE, IMMUNE SYSTEM 
3mlt:L     (SER1) to   (VAL109)  CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE  |   HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM 
3mlt:A     (TYR2) to   (VAL109)  CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE  |   HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM 
5erw:B     (TYR2) to   (ALA108)  STRUCTURE OF HCV E2 GLYCOPROTEIN ANTIGENIC EPITOPE II BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC84-26  |   IMMUNE SYSTEM, COMPLEX, HEPATITIS C VIRUS, E2 GLYCOPROTEIN, EPITOPE II, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
5esa:B     (TYR2) to   (ALA108)  CRYSTAL STRUCTURE OF ANTI-HCV E2 ANTIBODY HC84-26  |   HEPATITIS C VIRUS, E2 GLYCOPROTEIN, ANTIBODY, IMMUNE SYSTEM 
5etu:A     (LEU3) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH L5E MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5etu:C     (ILE2) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH L5E MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5f88:C     (LEU3) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5ff6:A     (ILE2) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5fhc:B     (TYR2) to   (VAL106)  CRYSTAL STRUCTURE OF PROTECTIVE HUMAN ANTIBODIES 100 AND 114 IN COMPLEX WITH EBOLA VIRUS FUSION GLYCOPROTEIN (GP)  |   IG DOMAIN, FAB, IMMUNE SYSTEM, FUSION, EBOLA VIRUS, GLYCOPROTEIN, GP, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4r7d:P     (ILE2) to   (ILE106)  FAB HU 15C1  |   TLR4 ANTIBODY, IMMUNE SYSTEM 
4r7n:F     (ILE2) to   (ILE106)  FAB C2E3  |   TLR4 ANTIBODY, IMMUNE SYSTEM 
4r7n:L     (ILE2) to   (THR109)  FAB C2E3  |   TLR4 ANTIBODY, IMMUNE SYSTEM 
4rau:A     (ASP3) to   (ILE108)  CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4  |   RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM 
4rau:D     (ASP3) to   (ILE108)  CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4  |   RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM 
4rau:G     (ASP3) to   (ILE108)  CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4  |   RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM 
4rau:J     (ASP3) to   (ILE108)  CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4  |   RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM 
4rau:M     (ASP3) to   (ILE108)  CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4  |   RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM 
4rau:P     (ASP3) to   (ILE108)  CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4  |   RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM 
4rau:S     (ASP3) to   (ILE108)  CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4  |   RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM 
4rau:V     (ASP3) to   (ILE108)  CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4  |   RTO,PF4,HIT, IMMUNOGLOBULIN, CXC CHEMOKINE, ANTIBODY, ANTIGEN, BLOOD, IMMUNE SYSTEM 
4rgo:L     (ASP1) to   (ALA109)  STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 14G8  |   NEUTRALIZING ANTIBODY, STAPHYLOCOCCAL ENTEROTOXIN B, TOXIN-IMMUNE SYSTEM COMPLEX 
3nh7:L     (ILE2) to   (VAL107)  CRYSTAL STRUCTURE OF THE NEUTRALIZING FAB FRAGMENT ABD1556 BOUND TO THE BMP TYPE I RECEPTOR IA  |   ANTIBODY-ANTIGEN COMPLEX, BMP RECEPTOR EXTRACELLULAR DOMAIN, BONE MORPHOGENETIC PROTEIN, IMMUNE SYSTEM 
3o2v:L     (LEU2) to   (THR109)  CRYSTAL STRUCTURE OF 1E9 PHEL89SER/LEUH47TRP/METH100BPHE, AN ENGINEERED DIELS-ALDERASE FAB WITH MODIFIED SPECIFICITY AND CATALYTIC ACTIVITY  |   IGG ANTIBODY FAB, IMMUNE SYSTEM 
3or6:B     (ILE2) to   (ALA109)  ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71Q  |   INACTIVATION, ALPHA-HELICAL, POTASSIUM CHANNEL, IMMUNE SYSTEM- TRANSPORT PROTEIN COMPLEX 
4dke:M     (ILE2) to   (ILE106)  CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB1.1  |   DIMERIC FOUR-HELIX BUNDLE CYTOKINE, IGG, GLYCOSYLATION, CYTOKINE- IMMUNE SYSTEM COMPLEX 
5hyq:A     (ILE2) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5hyq:C     (ILE2) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5i1d:L     (ASP1) to   (ILE112)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV4-1  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
5i2i:A     (ILE2) to   (THR109)  STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE  |   IMMUNE SYSTEM, ANTIBODY 
5i2i:C     (ILE2) to   (THR109)  STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE  |   IMMUNE SYSTEM, ANTIBODY 
5icy:A     (ILE2) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH LINEAR MEDITOPE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5icy:C     (ILE2) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH LINEAR MEDITOPE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5icx:C     (ILE2) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5icz:C     (ILE2) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH GQFDLSTRRLKG PEPTIDE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5id1:C     (ILE2) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5iop:C     (ILE2) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5ir1:A     (ILE2) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
3q6f:C     (TYR2) to   (VAL106)  CRYSTAL STRUCTURE OF FAB OF HUMAN MAB 2909 SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120  |   IGG, NEUTRALIZATION OF HIV-1 VIRUSES, QUATERNARY EPITOPE OF HIV-1 GP120, IMMUNE SYSTEM 
3q6f:I     (TYR2) to   (VAL106)  CRYSTAL STRUCTURE OF FAB OF HUMAN MAB 2909 SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120  |   IGG, NEUTRALIZATION OF HIV-1 VIRUSES, QUATERNARY EPITOPE OF HIV-1 GP120, IMMUNE SYSTEM 
3q6f:K     (TYR2) to   (VAL106)  CRYSTAL STRUCTURE OF FAB OF HUMAN MAB 2909 SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120  |   IGG, NEUTRALIZATION OF HIV-1 VIRUSES, QUATERNARY EPITOPE OF HIV-1 GP120, IMMUNE SYSTEM 
5iv2:C     (ILE2) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT  |   IMMUNE SYSTEM 
5j9p:B     (ILE2) to   (ALA109)  KCSA IN VITRO  |   MEMBRANE PROTEIN, ION CHANNEL, IN VITRO, METAL TRANSPORT 
3ra7:L     (ASP1) to   (ILE106)  BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY  |   FAB FRAGMENT, ANTIBODY ENGINEERING, CANCER, TARGETED PAYLOAD DELIVERY, IMMUNE SYSTEM 
5jo5:L     (GLU3) to   (THR105)  CRYSTAL STRUCTURE OF 10E8 GHV-GLV ANTIGEN-BINDING FRAGMENT.  |   MPER, HIV-1, ANTIBODY DEVELOPMENT, NEUTRALIZING, IMMUNE SYSTEM 
5jo5:B     (GLU3) to   (THR105)  CRYSTAL STRUCTURE OF 10E8 GHV-GLV ANTIGEN-BINDING FRAGMENT.  |   MPER, HIV-1, ANTIBODY DEVELOPMENT, NEUTRALIZING, IMMUNE SYSTEM 
5jo5:D     (GLU3) to   (THR105)  CRYSTAL STRUCTURE OF 10E8 GHV-GLV ANTIGEN-BINDING FRAGMENT.  |   MPER, HIV-1, ANTIBODY DEVELOPMENT, NEUTRALIZING, IMMUNE SYSTEM 
5jo5:F     (GLU3) to   (THR105)  CRYSTAL STRUCTURE OF 10E8 GHV-GLV ANTIGEN-BINDING FRAGMENT.  |   MPER, HIV-1, ANTIBODY DEVELOPMENT, NEUTRALIZING, IMMUNE SYSTEM 
5jxa:L     (GLU1) to   (VAL106)  CRYSTAL STRUCTURE OF LIGAND-FREE VRC03 ANTIGEN-BINDING FRAGMENT.  |   HIV-1, CD4 BINDING SITE, NEUTRALIZING, ANTIBODY DEVELOPMENT, IMMUNE SYSTEM 
4g3y:L     (ILE2) to   (THR109)  CRYSTAL STRUCTURE OF TNF-ALPHA IN COMPLEX WITH INFLIXIMAB FAB FRAGMENT  |   TNF, INFLIXIMAB, IMMUNE SYSTEM 
5kan:L     (ASP1) to   (THR109)  CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.G.07 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ  |   INFLUENZA, MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM 
4gms:L     (ASP1) to   (ALA109)  CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ  |   IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4gms:M     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ  |   IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4gms:N     (ASP1) to   (ALA109)  CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ  |   IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
5l0q:B     (ILE2) to   (ALA109)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ADAM10 D+C DOMAIN AND A CONFORMATION SPECIFIC MAB 8C7.  |   ADAM PROTEASE, MAB, 8C7, NOTCH SIGNALING, THERAPEUTIC ANTIBODY, CANCER STEM CELL, DRUG RESISTANCE, HYDROLASE-IMMUNE SYSTEM COMPLEX 
5l0q:E     (ILE2) to   (ALA109)  CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ADAM10 D+C DOMAIN AND A CONFORMATION SPECIFIC MAB 8C7.  |   ADAM PROTEASE, MAB, 8C7, NOTCH SIGNALING, THERAPEUTIC ANTIBODY, CANCER STEM CELL, DRUG RESISTANCE, HYDROLASE-IMMUNE SYSTEM COMPLEX 
5l9d:L     (ILE2) to   (MET106)  AFAMIN ANTIBODY FRAGMENT, N14 FAB, L1- GLYCOSYLATED, CRYSTAL FORM I, PARSIMONIOUS MODEL  |   AFAMIN ANTIBODY, FAB FRAGMENT, IGG1-KAPPA, LIGHT CHAIN GLYCOSILATION, IMMUNE SYSTEM 
5t1k:A     (ILE2) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5t1k:C     (ILE2) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5t1l:A     (LEU3) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH CQA(PH)2DLSTRRLKC PEPTIDE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5t1l:C     (LEU3) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH CQA(PH)2DLSTRRLKC PEPTIDE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5t1m:A     (ILE2) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH CQYDLSTRRLKC  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
4gw1:C     (ILE2) to   (THR109)  CQFD MEDITOPE  |   IGG, IMMUNE SYSTEM, EGFR 
1ad0:A     (VAL3) to   (THR108)  FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY A5B7  |   IMMUNOGLOBULIN, FAB FRAGMENT 
1ad0:C     (VAL3) to   (THR108)  FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY A5B7  |   IMMUNOGLOBULIN, FAB FRAGMENT 
1ay1:L     (GLN3) to   (LEU106)  ANTI TAQ FAB TP7  |   IMMUNOGLOBULIN, ANTIBODY, FAB, ENZYME INHIBITOR, PCR, HOT START 
4hbc:L     (ASP1) to   (ASP111)  CRYSTAL STRUCTURE OF A CONFORMATION-DEPENDENT RABBIT IGG FAB SPECIFIC FOR AMYLOID PREFIBRILLAR OLIGOMERS  |   FAB, RABBIT, CONFORMATION-SPECIFIC, AMYLOID, IMMUNE SYSTEM 
4hg4:U     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ  |   VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4hix:L     (VAL3) to   (THR109)  CRYSTAL STRUCTURE OF A HUMANISED 3D6 FAB BOUND TO AMYLOID BETA PEPTIDE  |   IMMUNOGLOBULIN, IMMUNOTHERAPY CANDIDATE, AMYLOID BETA PEPTIDE, PROTEIN FIBRIL-IMMUNE SYSTEM COMPLEX 
3eyo:A     (GLU1) to   (ILE107)  CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9  |   HUMAN CYTOMEGALOVIRUS, ANTIBODY, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
1bre:A     (ILE2) to   (ILE106)  IMMUNOGLOBULIN LIGHT CHAIN PROTEIN  |   IMMUNOGLOBULIN 
1bre:E     (ILE2) to   (ILE106)  IMMUNOGLOBULIN LIGHT CHAIN PROTEIN  |   IMMUNOGLOBULIN 
3sge:L     (VAL2) to   (ILE111)  CRYSTAL STRUCTURE OF MAB 17.2 IN COMPLEX WITH R13 PEPTIDE  |   IMMUNOGLOBULIN, ANTIGEN BINDING, IMMUNE SYSTEM 
1ott:F     (ASP1) to   (ILE105)  STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148A MUTANT AND FAB COMPLEX  |   CHLORIDE CHANNEL, FAB COMPLEX, ION CHANNEL, MEMBRANE PROTEIN 
4xpa:L     (ASN2) to   (MET107)  X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO 3, 4DICHLOROPHENETHYLAMINE  |   INTEGRAL MEMBRANE PROTEIN, ALL-ALPHA HELICAL ANTIDEPRESSANT COMPLEX, TRANSPORT PROTEIN-INHIBITOR COMPLEX 
1dcl:A     (SER2) to   (VAL109)  MCG, A LAMBDA V TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN), CRYSTALLIZED FROM AMMONIUM SULFATE  |   IMMUNOGLOBULIN, BENCE JONES, ANTIBODY, MULTIPLE QUATERNARY STRUCTURES 
1r3l:A     (ILE2) to   (ALA109)  POTASSIUM CHANNEL KCSA-FAB COMPLEX IN CS+  |   MEMBRANE PROTEIN, POTASSIUM CHANNEL, KCSA-FAB COMPLEX, CESIUM 
1rjl:A     (ASP1) to   (ILE106)  STRUCTURE OF THE COMPLEX BETWEEN OSPB-CT AND BACTERICIDAL FAB-H6831  |   BETA SHEET, ANTIBODY-PROTEIN COMPLEX, IMMUNE SYSTEM 
2vdr:L     (ILE2) to   (ILE106)  INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE, LGGAKQRGDV  |   CELL ADHESION-IMMUNE SYSTEM COMPLEX, FIBRINOGEN BINDING, PLATELET INTEGRIN ALPHAIIBBETA3, GLYCOPROTEIN, CELL ADHESION, MEMBRANE, INTEGRIN, RECEPTOR, ANTAGONIST, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, TRANSMEMBRANE, PHOSPHORYLATION, DISEASE MUTATION, CLEAVAGE ON PAIR OF BASIC RESIDUES, CELL ADHESION/IMMUNE SYSTEM COMPLEX 
4kjp:D     (ASP1) to   (ALA108)  STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE  |   MEMBRANE TRANSPORTING PROTEIN, TRANPORT PROTEIN, MEMBRANE PROTEIN 
4kjp:F     (ASP1) to   (ALA108)  STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN THE ABSENCE OF HALIDE  |   MEMBRANE TRANSPORTING PROTEIN, TRANPORT PROTEIN, MEMBRANE PROTEIN 
3i75:A     (ILE2) to   (LEU106)  ANTIBODY STRUCTURE  |   ANTIBODY, IGG, IMMUNE SYSTEM 
4zpv:B     (ASP1) to   (LEU106)  STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 2)  |   VACCINE, IMMUNOGEN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4lar:L     (ILE2) to   (ILE106)  CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN THE FREE FORM AND IN COMPLEX WITH AMPHETAMINE AND 4-HYDROXYMETHAMPHETAMINE  |   METHAMPHETAMINE, ANTI-METHAMPHETAMINE ANTIBODY, THERAPEUTIC ANTIBODY, SCFV, IMMUNE SYSTEM 
4zyp:L     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN  |   IG DOMAIN, FAB, IMMUNE SYSTEM, FUSION, RESPIRATORY SYNCYTIAL VIRUS, PREFUSION 
4zyp:M     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN  |   IG DOMAIN, FAB, IMMUNE SYSTEM, FUSION, RESPIRATORY SYNCYTIAL VIRUS, PREFUSION 
4zyp:O     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN  |   IG DOMAIN, FAB, IMMUNE SYSTEM, FUSION, RESPIRATORY SYNCYTIAL VIRUS, PREFUSION 
1uwe:L     (ASN2) to   (THR109)  MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9  |   ANTIBODY 
1uwe:U     (ASP1) to   (THR109)  MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9  |   ANTIBODY 
1uwe:X     (ASN2) to   (THR109)  MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9  |   ANTIBODY 
2itc:B     (ILE2) to   (ALA109)  POTASSIUM CHANNEL KCSA-FAB COMPLEX IN SODIUM CHLORIDE  |   VOLTAGE-GATED CHANNEL, TRANSMEMBRANE, IONIC CHANNEL, ION TRANSPORT, K CHANNEL, PROTEIN-ANTIBODY FAB COMPLEX, MEMBRANE PROTEIN 
2znx:A     (ILE2) to   (ILE106)  5-FLUOROTRYPTOPHAN INCORPORATED SCFV10 COMPLEXED TO HEN EGG LYSOZYME  |   FLUOROTRYPTOHPAN, 5-FLUOROTRYPTOPHAN, 19F, SINGLE CHAIN FV, LYSOZYME, ALLERGEN, ANTIMICROBIAL, BACTERIOLYTIC ENZYME, GLYCOSIDASE, HYDROLASE, IMMUNE SYSTEM-HYDROLASE COMPLEX 
2znx:B     (ILE2) to   (ILE106)  5-FLUOROTRYPTOPHAN INCORPORATED SCFV10 COMPLEXED TO HEN EGG LYSOZYME  |   FLUOROTRYPTOHPAN, 5-FLUOROTRYPTOPHAN, 19F, SINGLE CHAIN FV, LYSOZYME, ALLERGEN, ANTIMICROBIAL, BACTERIOLYTIC ENZYME, GLYCOSIDASE, HYDROLASE, IMMUNE SYSTEM-HYDROLASE COMPLEX 
1mlb:A     (GLU3) to   (ILE106)  MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
3lex:L     (VAL3) to   (ILE111)  2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 11F10 IN COMPLEX WITH HIV-1 GP41  |   HIV-1, GP-41, MONOCLONAL ANTIBODY, 2F5, SCAFFOLD, EPITOPE, TRANSPLANT, GRAFT, RE-ELCITATION, ENVELOPE PROTEIN, IMMUNE SYSTEM, VACCINE DESIGN 
3mac:L     (ILE2) to   (THR106)  CRYSTAL STRUCTURE OF GP41-DERIVED PROTEIN COMPLEXED WITH FAB 8062  |   GP41, FAB8062, IMMUNE SYSTEM 
2adf:L     (ILE2) to   (ILE105)  CRYSTAL STRUCTURE AND PARATOPE DETERMINATION OF 82D6A3, AN ANTITHROMBOTIC ANTIBODY DIRECTED AGAINST THE VON WILLEBRAND FACTOR A3-DOMAIN  |   ON WILLEBRAND FACTOR, A3-DOMAIN, 82D6A3, COLLAGEN BINDING, PARATOPE, EPITOPE, ANTITHROMBOTIC, BLOOD CLOTTING-IMMUNE SYSTEM COMPLEX 
5eoc:M     (ILE2) to   (ALA113)  CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I  |   COMPLEX, MONOCLONAL ANTIBODIES, HCV, IMMUNE SYSTEM 
5esq:C     (LEU3) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH CYCLIC BETA-ALANINE-LINKED MEDITOPE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5euk:A     (ILE2) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5euk:C     (ILE2) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
4rir:L     (ASN1) to   (THR105)  STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK  |   ANTIBODY, IGG FOLD, IMMUNE SYSTEM, HIV-1 GP120 V2 REGION 
3ogc:B     (ILE2) to   (ILE106)  KCSA E71A VARIANT IN PRESENCE OF NA+  |   VOLTAGE-GATED CHANNEL, ANTIBODY FAB COMPLEX, MEMBRANE PROTEIN 
3piq:D     (VAL3) to   (VAL106)  CRYSTAL STRUCTURE OF HUMAN 2909 FAB, A QUATERNARY STRUCTURE-SPECIFIC ANTIBODY AGAINST HIV-1  |   MONOCLONAL ANTIBODY, NEUTRALIZING, HIV-1, QUATERNARY EPITOPE, TRIMERIC ENVELOPE SPIKE, IMMUNE SYSTEM 
3piq:F     (VAL3) to   (VAL106)  CRYSTAL STRUCTURE OF HUMAN 2909 FAB, A QUATERNARY STRUCTURE-SPECIFIC ANTIBODY AGAINST HIV-1  |   MONOCLONAL ANTIBODY, NEUTRALIZING, HIV-1, QUATERNARY EPITOPE, TRIMERIC ENVELOPE SPIKE, IMMUNE SYSTEM 
3piq:K     (VAL3) to   (VAL106)  CRYSTAL STRUCTURE OF HUMAN 2909 FAB, A QUATERNARY STRUCTURE-SPECIFIC ANTIBODY AGAINST HIV-1  |   MONOCLONAL ANTIBODY, NEUTRALIZING, HIV-1, QUATERNARY EPITOPE, TRIMERIC ENVELOPE SPIKE, IMMUNE SYSTEM 
5id0:C     (ILE2) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH AMINOHEPTANOIC ACID-LINKED MEDITOPE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
5itf:C     (LEU3) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT  |   IMMUNE SYSTEM 
5ivz:C     (LEU3) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH ARG8CIR MEDITOPE VARIANT  |   IMMUNE SYSTEM 
4fqq:L     (TYR3) to   (VAL106)  CRYSTAL STRUCTURE OF GERMLINE ANTIBODY PGT121-GL FAB  |   IG FOLD, ANTI HIV, ANTIBODY, IMMUNE SYSTEM 
4g6k:L     (ASP1) to   (ILE106)  CRYSTAL STRUCTURE OF THE THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB IN ITS UNBOUND STATE  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, CYTOKINE, INTERLEUKINE-1BETA 
4g6m:L     (ILE2) to   (ILE106)  CRYSTAL STRUCURE OF HUMAN IL-1BETA IN COMPLEX WITH THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, INTERLEUKINE-1BETA 
5th2:A     (ILE2) to   (THR109)  CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM